{"pmid":32387085,"title":"Potential implications of novel coronavirus disease (COVID-19) related gastrointestinal symptoms for abdominal imaging.","text":["Potential implications of novel coronavirus disease (COVID-19) related gastrointestinal symptoms for abdominal imaging.","Radiography (Lond)","Wilson, M P","Katlariwala, P","Low, G","32387085"],"journal":"Radiography (Lond)","authors":["Wilson, M P","Katlariwala, P","Low, G"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387085","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.radi.2020.04.016","keywords":["2019-ncov","abdomen","covid-19","gastrointestinal","imaging","sars-cov-2"],"topics":["Diagnosis"],"weight":1,"_version_":1666428892561276928,"score":9.490897,"similar":[{"pmid":32429041,"title":"COVID-19 and Gastrointestinal Symptoms-A Case Report.","text":["COVID-19 and Gastrointestinal Symptoms-A Case Report.","COVID-19, a new illness secondary to a novel Coronavirus emerged in December 2019 in China. Our early understanding of the clinical features of COVID-19 has been based on case series emerging from the first outbreak in Wuhan. These features included fever, a dry cough, myalgia and dyspnea. Gastrointestinal symptoms were rarely reported as a key feature. We present a case report of a 74-year-old male who presented with symptoms of gastroenteritis and subsequently tested positive for COVID-19. This article aims to highlight an uncommon presentation of COVID-19 and that a high index of suspicion is required for COVID-19 in older people given their greater likelihood of presenting atypically.","Geriatrics (Basel)","Mackett, Alistair J","Keevil, Victoria L","32429041"],"abstract":["COVID-19, a new illness secondary to a novel Coronavirus emerged in December 2019 in China. Our early understanding of the clinical features of COVID-19 has been based on case series emerging from the first outbreak in Wuhan. These features included fever, a dry cough, myalgia and dyspnea. Gastrointestinal symptoms were rarely reported as a key feature. We present a case report of a 74-year-old male who presented with symptoms of gastroenteritis and subsequently tested positive for COVID-19. This article aims to highlight an uncommon presentation of COVID-19 and that a high index of suspicion is required for COVID-19 in older people given their greater likelihood of presenting atypically."],"journal":"Geriatrics (Basel)","authors":["Mackett, Alistair J","Keevil, Victoria L"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32429041","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3390/geriatrics5020031","keywords":["covid-19","gastrointestinal","older"],"locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1667342288133554176,"score":70.31991},{"pmid":32388469,"title":"Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19.","text":["Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19.","There is an increasing number of confirmed cases and deaths caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributing to the Coronavirus disease 2019 (COVID-19) pandemic. At this point, the need for further disease characterization is critical. COVID-19 is well established as a respiratory tract pathogen; however, recent studies have shown an increasing number of patients reporting gastrointestinal manifestations such as diarrhea, nausea, vomiting, and abdominal pain. The time from onset of gastrointestinal symptoms to hospital presentation is often delayed compared to that of respiratory symptoms. It has been noted that SARS-CoV-2 RNA can be detected in fecal matter for an extended period of time, even after respiratory samples have tested negative and patients are asymptomatic. In this article, SARS-CoV-2 and its disease COVID-19 will be reviewed with consideration of the latest literature about gastrointestinal symptomatology, the mechanisms by which the virus may inflict damage, and the possibility of viral replication contributing to a fecal-oral route of transmission.","J Clin Virol","Patel, Kishan P","Patel, Puja A","Vunnam, Rama R","Hewlett, Alexander T","Jain, Rohit","Jing, Ran","Vunnam, Srinivas R","32388469"],"abstract":["There is an increasing number of confirmed cases and deaths caused by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contributing to the Coronavirus disease 2019 (COVID-19) pandemic. At this point, the need for further disease characterization is critical. COVID-19 is well established as a respiratory tract pathogen; however, recent studies have shown an increasing number of patients reporting gastrointestinal manifestations such as diarrhea, nausea, vomiting, and abdominal pain. The time from onset of gastrointestinal symptoms to hospital presentation is often delayed compared to that of respiratory symptoms. It has been noted that SARS-CoV-2 RNA can be detected in fecal matter for an extended period of time, even after respiratory samples have tested negative and patients are asymptomatic. In this article, SARS-CoV-2 and its disease COVID-19 will be reviewed with consideration of the latest literature about gastrointestinal symptomatology, the mechanisms by which the virus may inflict damage, and the possibility of viral replication contributing to a fecal-oral route of transmission."],"journal":"J Clin Virol","authors":["Patel, Kishan P","Patel, Puja A","Vunnam, Rama R","Hewlett, Alexander T","Jain, Rohit","Jing, Ran","Vunnam, Srinivas R"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32388469","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.jcv.2020.104386","keywords":["covid 19","gastrointestinal","hepatobiliary","pandemic","sars-cov-2"],"topics":["Diagnosis","Transmission"],"weight":1,"_version_":1666428892546596864,"score":67.20201},{"pmid":32476796,"pmcid":"PMC7243653","title":"Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.","text":["Gastrointestinal and hepatic manifestations of COVID-19: A comprehensive review.","The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) that causes coronavirus disease-2019 (COVID-19) is a global pandemic, manifested by an infectious pneumonia. Although patients primarily present with fever, cough and dyspnea, some patients also develop gastrointestinal (GI) and hepatic manifestations. The most common GI symptoms reported are diarrhea, nausea, vomiting, and abdominal discomfort. Liver chemistry abnormalities are common and include elevation of aspartate transferase, alanine transferase, and total bilirubin. Studies have shown that SARS-CoV-2 infects the GI tract via its viral receptor angiotensin converting enzyme II, which is expressed on enterocytes of the ileum and colon. Viral RNA has also been isolated from stool specimens of COVID-19 patients, which raised the concern for fecal-oral transmission in addition to droplet transmission. Although indirect evidence has suggested possible fecal-oral transmission of SARS-CoV-2, more effort is needed to establish the role of the fecal-oral transmission route. Further research will help elucidate the association between patients with underlying GI diseases, such as chronic liver disease and inflammatory bowel disease, and severity of COVID-19. In this review, we summarize the data on GI involvement to date, as well as the impact of COVID-19 on underlying GI diseases.","World J Gastroenterol","Cha, Ming Han","Regueiro, Miguel","Sandhu, Dalbir S","32476796"],"abstract":["The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) that causes coronavirus disease-2019 (COVID-19) is a global pandemic, manifested by an infectious pneumonia. Although patients primarily present with fever, cough and dyspnea, some patients also develop gastrointestinal (GI) and hepatic manifestations. The most common GI symptoms reported are diarrhea, nausea, vomiting, and abdominal discomfort. Liver chemistry abnormalities are common and include elevation of aspartate transferase, alanine transferase, and total bilirubin. Studies have shown that SARS-CoV-2 infects the GI tract via its viral receptor angiotensin converting enzyme II, which is expressed on enterocytes of the ileum and colon. Viral RNA has also been isolated from stool specimens of COVID-19 patients, which raised the concern for fecal-oral transmission in addition to droplet transmission. Although indirect evidence has suggested possible fecal-oral transmission of SARS-CoV-2, more effort is needed to establish the role of the fecal-oral transmission route. Further research will help elucidate the association between patients with underlying GI diseases, such as chronic liver disease and inflammatory bowel disease, and severity of COVID-19. In this review, we summarize the data on GI involvement to date, as well as the impact of COVID-19 on underlying GI diseases."],"journal":"World J Gastroenterol","authors":["Cha, Ming Han","Regueiro, Miguel","Sandhu, Dalbir S"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32476796","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3748/wjg.v26.i19.2323","keywords":["covid-19","diarrhea","gastrointestinal","inflammatory bowel disease","liver","sars-cov-2"],"e_drugs":["Alanine","Aspartic Acid","Bilirubin"],"topics":["Diagnosis","Mechanism","Transmission"],"weight":1,"_version_":1668532089544245248,"score":66.78235},{"pmid":32462689,"title":"Features of Enteric Disease from Human Coronaviruses: Implications for COVID-19.","text":["Features of Enteric Disease from Human Coronaviruses: Implications for COVID-19.","Coronaviruses have long been studied in both human and veterinary fields. Whereas the initial detection of endemic human respiratory coronaviruses was problematic, detection of these and newly discovered human coronaviruses has been greatly facilitated with major advances in the laboratory. Nevertheless, technological factors can affect the accuracy and timeliness of virus detection. Many human coronaviruses can be variably found in stool samples. All human coronaviruses have been variably associated with symptoms of gastroenteritis. Coronaviruses can occasionally be cultured from enteric specimens, but most detection is accomplished with genetic amplification technologies. Excretion of viral RNA in stool can extend for a prolonged period. Culture-positive stool samples have been found to exceed a fourteen day period after onset of infection for some coronaviruses. Virus can also sometimes be cultured from patients' respiratory samples during the late incubation period. Relatively asymptomatic patients may excrete virus. Both viable and non-viable virus can be found in the immediate environment of the patient, the health care worker, and less often the public. These lessons from the past study of animal and human coronaviruses can be extended to presumptions for SARS-CoV-2. Already, the early reports from the COVID-19 pandemic are confirming some concerns. This data has the cumulative potential to cause us to rethink some current and common public health and infection control strategies. This article is protected by copyright. All rights reserved.","J Med Virol","Cimolai, Nevio","32462689"],"abstract":["Coronaviruses have long been studied in both human and veterinary fields. Whereas the initial detection of endemic human respiratory coronaviruses was problematic, detection of these and newly discovered human coronaviruses has been greatly facilitated with major advances in the laboratory. Nevertheless, technological factors can affect the accuracy and timeliness of virus detection. Many human coronaviruses can be variably found in stool samples. All human coronaviruses have been variably associated with symptoms of gastroenteritis. Coronaviruses can occasionally be cultured from enteric specimens, but most detection is accomplished with genetic amplification technologies. Excretion of viral RNA in stool can extend for a prolonged period. Culture-positive stool samples have been found to exceed a fourteen day period after onset of infection for some coronaviruses. Virus can also sometimes be cultured from patients' respiratory samples during the late incubation period. Relatively asymptomatic patients may excrete virus. Both viable and non-viable virus can be found in the immediate environment of the patient, the health care worker, and less often the public. These lessons from the past study of animal and human coronaviruses can be extended to presumptions for SARS-CoV-2. Already, the early reports from the COVID-19 pandemic are confirming some concerns. This data has the cumulative potential to cause us to rethink some current and common public health and infection control strategies. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Cimolai, Nevio"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462689","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26066","keywords":["covid-19","sars-cov-2","coronavirus","gastrointestinal","infection"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1668079521461436416,"score":64.921814},{"pmid":32301631,"title":"Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms.","text":["Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms.","OBJECTIVE. This series of patients presented to the emergency department (ED) with abdominal pain, without the respiratory symptoms typical of coronavirus disease (COVID-19), and the abdominal radiologist was the first to suggest COVID-19 infection because of findings in the lung bases on CT of the abdomen. CONCLUSION. COVID-19 infection can present primarily with abdominal symptoms, and the abdominal radiologist must suggest the diagnosis when evaluating the lung bases for typical findings.","AJR Am J Roentgenol","Siegel, Avielle","Chang, Paul J","Jarou, Zachary J","Paushter, David M","Harmath, Carla B","Arevalo, J Ben","Dachman, Abraham","32301631"],"abstract":["OBJECTIVE. This series of patients presented to the emergency department (ED) with abdominal pain, without the respiratory symptoms typical of coronavirus disease (COVID-19), and the abdominal radiologist was the first to suggest COVID-19 infection because of findings in the lung bases on CT of the abdomen. CONCLUSION. COVID-19 infection can present primarily with abdominal symptoms, and the abdominal radiologist must suggest the diagnosis when evaluating the lung bases for typical findings."],"journal":"AJR Am J Roentgenol","authors":["Siegel, Avielle","Chang, Paul J","Jarou, Zachary J","Paushter, David M","Harmath, Carla B","Arevalo, J Ben","Dachman, Abraham"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301631","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.2214/AJR.20.23232","keywords":["covid-19","sars-cov-2","abdominal ct","coronavirus","imaging findings","lung bases"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494791057409,"score":62.08755}]}